CASQ2 Protein (Myc-DYKDDDDK Tag)

N° du produit ABIN2713078

Détail du produit

Antigène: CASQ2 (Calsequestrin 2 (CASQ2))

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette CASQ2 protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human Calsequestrin-2 protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: CASQ2 (Calsequestrin 2 (CASQ2))

Autre désignation: Calsequestrin-2 (CASQ2 Produits)

Synonymes: CASQ2 Protein, DKFZp468D075 Protein, AA033488 Protein, AW146219 Protein, ESTM52 Protein, cCSQ Protein, PDIB2 Protein, cardCSQ Protein, CASQ1 Protein, CAL Protein, calsequestrin 2 Protein, CASQ2 Protein, Casq2 Protein

Sujet: The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest.

Poids moléculaire: 44.2 kDa

NCBI Accession: NP_001223

Pathways: Negative Regulation of Transporter Activity